When taken, does Buspar (buspirone) decrease or increase serotonin?

Buspar Increases Serotonin Activity

Buspar (buspirone) increases serotonin activity in the brain, but through a unique mechanism—it acts as a partial agonist at serotonin 5-HT1A receptors, which paradoxically decreases serotonin release acutely while increasing dopamine and noradrenaline. 1

Mechanism of Action

Buspirone has a high affinity for serotonin 5-HT1A receptors where it functions as a partial agonist 1. This means it activates these receptors but not to the full extent that serotonin itself would. The drug has no significant affinity for benzodiazepine receptors and does not affect GABA binding 1.

Acute Effects on Neurotransmitters

When buspirone is first administered:

• Serotonin levels decrease by approximately 50% in the frontal cortex 2, 3, 4
• Dopamine levels increase by approximately 100% 2, 3
• Noradrenaline levels increase by approximately 140-160% 2, 3

This acute decrease in serotonin occurs because buspirone activates presynaptic 5-HT1A autoreceptors on serotonergic neurons, which inhibits the firing of these neurons and reduces serotonin synthesis and release 3, 4.

Chronic Effects: The Key Difference

With chronic administration (14 days or more), the picture changes dramatically:

• 5-HT1A autoreceptors become desensitized 4, 5
• Serotonin synthesis normalizes and returns to baseline or higher levels 4, 5
• The increases in dopamine and noradrenaline persist 5

This desensitization of autoreceptors is thought to be crucial for buspirone's therapeutic effects and explains why it takes several weeks to achieve full anxiolytic benefit 6, 7.

Clinical Implications

Serotonin Syndrome Risk

Despite initially decreasing serotonin release, buspirone is classified as a serotonergic medication and can contribute to serotonin syndrome when combined with other serotonergic drugs 8, 9. The guidelines specifically warn about combining buspirone with:

• MAO inhibitors
• SSRIs and SNRIs
• Tricyclic antidepressants
• Opioids with serotonergic activity (tramadol, meperidine, fentanyl, methadone)
• Triptans
• Dextromethorphan
• St. John's wort

Caution requires starting any second serotonergic drug at a low dose, increasing slowly, and monitoring for symptoms especially in the first 24-48 hours after dosage changes 8.

Interaction with SSRIs

When buspirone is combined with SSRIs like fluoxetine:

• It attenuates the SSRI-induced increase in serotonin levels 3, 10
• It potentiates the SSRI-induced increases in dopamine and noradrenaline by 2-3 fold 3, 10
• This may explain why buspirone augmentation can enhance antidepressant effects in clinical practice 11, 10

Common Pitfalls

1. Don't assume buspirone simply "increases serotonin"—the mechanism is more complex, involving initial decreases followed by normalization with chronic use

2. Don't ignore serotonin syndrome risk—even though buspirone acutely decreases serotonin, it still acts on serotonergic pathways and requires caution when combining with other serotonergic agents 8

3. Don't expect immediate effects—the desensitization of 5-HT1A autoreceptors takes 2-4 weeks, which is why buspirone requires sustained treatment for full therapeutic benefit 12, 7

4. Monitor for dose-dependent effects—low doses (0.1 mg/kg) may enhance cognitive function through different receptor dynamics than higher doses (3 mg/kg) 13